Spruce Biosciences, Inc. - Common Stock — Cash Flow (NASDAQ:SPRB) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -27.52 M-35.88 M-41.68 M-33.27 M-55.96 M-33.33 M -29.33 M Cash from investing activities -74 K-79.17 M23.69 M55.78 M0— — Cash from financing activities 181.03 M643 K-241 K49.14 M-1.62 M43.48 M 57.81 M Free cash flow -27.52 M-35.88 M-41.68 M-33.27 M-55.96 M-33.33 M -29.34 M

News

Spruce Biosciences names Dale Hooks as chief commercial officer

3 ‘Strong Buy’ Stocks to Buy Now, 2/6/2026, According to Top Analysts - TipRanks.com

Big-Pharma Partner Harbour BioMed Boosts Stake In Spruce Biosciences - Spruce Biosciences (NASDAQ:SPRB)

Biotech Stocks' Dark Winter Is Over. What That Means For Investors.

Oppenheimer initiates coverage on Spruce Biosciences stock with Outperform rating

This Levi Strauss Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Brunswick (NYSE:BC), Cellectis (NASDAQ:CLLS)

Spruce Biosciences stock rating resumed at Buy by H.C. Wainwright

Leerink Partners upgrades Spruce Biosciences stock to Outperform

Citizens raises Spruce Biosciences stock price target to $259 on MPS IIIB therapy

Spruce Biosciences stock upgraded by Citizens on promising MPS IIIB therapy

Spruce Biosciences stock price target raised to $160 from $10 at Leerink

What Makes Spruce Biosciences, Inc. (SPRB) a Strong Momentum Stock: Buy Now?